共 100 条
[1]
Haugen BR(2016)2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer Thyroid 26 1-133
[2]
Alexander EK(2021)Improving the prediction of persistent and recurrent differentiated thyroid cancer using the American Thyroid Association 2015 risk stratification system Hormones 20 761-768
[3]
Bible KC(2014)Consenso intersocietario sobre tratamiento y seguimiento de pacientes con cáncer diferenciado de tiroides Rev. Arg. Endocrinol. Metab. 51 85-118
[4]
Markantes GK(2010)Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioiodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association guidelines Thyroid 20 1341-1349
[5]
Karakioulaki M(2011)In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response Thyroid 21 1317-1322
[6]
Papanikolopoulou S(2012)Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy Clin. Endocrinol. (Oxf.) 77 132-138
[7]
Pitoia F(2013)Outcomes of patients with differentiated thyroid cancer risk stratified according to the American Thyroid Association and Latin American Thyroid Society risk of recurrence classification systems Thyroid 23 1401-1407
[8]
Califano I(2015)Implementing the modified 2009 American Thyroid Association risk stratification system in thyroid cancer patients with low and intermediate risk of recurrence Thyroid 25 1235-1242
[9]
Vázquez A(2012)Ablation with low –dose radioiodine and thyrotrophin alpha in thyroid cancer N. Engl. J. Med. 366 1674-1685
[10]
Tuttle RM(2012)Strategies of radioiodine ablation in patients with low-risk thyroid cancer N. Engl. J. Med. 366 1663-1673